Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients

NCT01276899 is registered in ClinicalTrials.gov with Jewish General Hospital as lead sponsor.

NCT NCT01276899
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01276899 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Study to Identify Molecular Mechanisms of Clinical Resistance to Chemotherapy in Triple Negative Breast Cancer Patients
Lead sponsor
Jewish General Hospital
Phase
Observational
Overall status
Completed
Start date
September 30, 2010
Completion date
Not reported
Enrollment
80 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

triple negative breast cancer